Heart Attack Complications Study
Part of Genetic & congenital, Heart & circulation clinical trials.
This study looks at people who have had a heart attack and developed a related structural problem in the heart (like a tear or valve issue). It aims to learn more about these complications to improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You've been diagnosed with a heart attack (myocardial infarction).
- Your heart attack led to a mechanical complication, such as a tear in the heart wall or a problem with a valve.
- If you had a tear in your heart, it must be related to your heart attack—not due to another cause.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at what happens after complications during or after a heart procedure called coronary angiography or PCI. It may help improve care and outcomes for people who experience a problem during treatment.
This study looks at people who have had a heart attack and were treated with a procedure to open blocked heart arteries. The goal is to find better ways to predict who might have serious problems afterward, so doctors can help prevent them.
This study looks at how often complications happen and long-term survival in people having complex coronary procedures. It may help doctors understand which treatments work best for complex heart disease.
This study looks at the serious risks of a procedure that treats irregular heartbeats. It aims to understand how often complications happen and what they are, which can help doctors improve safety.
This study looks at people who had a heart attack or cardiac arrest to find out which dangerous heart rhythms can happen afterward. The goal is to improve care and prevent future problems.
This study looks at treatment options for adults with significantly reduced heart pumping strength and extensive coronary artery disease. It may help people who are at higher risk due to widespread blocked heart arteries, but eligibility depends on recent heart events and bleeding risk.
Hear when a new Ventricular Septal Defect trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.